Name | ML349 |
---|
Description | ML349 is a potent and specific acyl protein thioesterase 2 (APT-2) inhibitor with a Ki of 120 nM. ML349 is also an inhibitor of LYPLA2 with an IC50 of 144 nM. |
---|---|
Related Catalog | |
Target |
Ki: 120 nM (APT-2)[1] IC50: 144 nM (LYPLA2)[2] |
In Vitro | ML349 is an inhibitor of acyl protein thioesterase 1 and 2 (APT-1 and APT-2) with Kis of >10000 and 120±20 nM, respectively[1]. ML349 is also an inhibitor of both LYPLA1 and LYPLA2 with IC50s of >3000 and 144 nM, respectivley[2]. ML348 and ML349 do not decrease cell viability, but they lead to a slight activation of AKT in NRAS mutant cells[3]. |
Cell Assay | Cells are plated in 96-well plates with a density of 4000 to 8000 cells per well and incubated for 24 h at 37°C with 5% CO2. Then cells are treated with increasing drug (including ML349) concentrations and their combinations. Cell viability is measured with the cell viability assay according to the manufacturer's protocol[3]. |
References |
Molecular Formula | C23H22N2O4S2 |
---|---|
Molecular Weight | 454.56 |
Storage condition | 2-8℃ |